Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laurence S Magder

Showing results (1-10 of 216) with videos related to

Pageof 22
Sort By:
Controlled Clinical Trials|July 17, 2003
Simple approaches to assess the possible impact of missing outcome information on estimates of risk ratios, odds ratios, and risk differencesLaurence S Magder
Arthritis & Rheumatology (Hoboken, N.J.)|May 29, 2018
Comparison of Remission and Lupus Low Disease Activity State in Damage Prevention in a United States Systemic Lupus Erythematosus CohortMichelle Petri, Laurence S Magder
American Journal of Epidemiology|October 2, 2012
Incidence of and risk factors for adverse cardiovascular events among patients with systemic lupus erythematosusLaurence S Magder, Michelle Petri
Arthritis & Rheumatology (Hoboken, N.J.)|August 19, 2018
ReplyMichelle Petri, Laurence S Magder
Arthritis & Rheumatology (Hoboken, N.J.)|May 27, 2021
ReplyMichelle Petri, Laurence S Magder
Journal of Clinical Epidemiology|October 22, 2003
Optimal choice of a cut point for a quantitative diagnostic test performed for research purposesLaurence S Magder, Alan D Fix
The Journal of Rheumatology|June 3, 2016
Dr. Durcan, et al replyLaura Durcan, Laurence S Magder, Michelle Petri
The Journal of Rheumatology|August 17, 2014
Predictors of incident depression in systemic lupus erythematosusXiangyang Huang, Laurence S Magder, Michelle Petri
The Journal of Rheumatology|December 5, 2002
Antiphospholipid antibodies and incidence of venous thrombosis in a cohort of patients with systemic lupus erythematosusEmily Somers, Laurence S Magder, Michelle Petri
Lupus Science & Medicine|December 22, 2015
Lupus anticoagulant, disease activity and low complement in the first trimester are predictive of pregnancy lossAnil Mankee, Michelle Petri, Laurence S Magder
Pageof 22

Showing results (1-10 of 216) with videos related to

Sort By:
Pageof 22
Controlled Clinical Trials|July 17, 2003
Simple approaches to assess the possible impact of missing outcome information on estimates of risk ratios, odds ratios, and risk differencesLaurence S Magder
Arthritis & Rheumatology (Hoboken, N.J.)|May 29, 2018
Comparison of Remission and Lupus Low Disease Activity State in Damage Prevention in a United States Systemic Lupus Erythematosus CohortMichelle Petri, Laurence S Magder
American Journal of Epidemiology|October 2, 2012
Incidence of and risk factors for adverse cardiovascular events among patients with systemic lupus erythematosusLaurence S Magder, Michelle Petri
Arthritis & Rheumatology (Hoboken, N.J.)|August 19, 2018
ReplyMichelle Petri, Laurence S Magder
Arthritis & Rheumatology (Hoboken, N.J.)|May 27, 2021
ReplyMichelle Petri, Laurence S Magder
Journal of Clinical Epidemiology|October 22, 2003
Optimal choice of a cut point for a quantitative diagnostic test performed for research purposesLaurence S Magder, Alan D Fix
The Journal of Rheumatology|June 3, 2016
Dr. Durcan, et al replyLaura Durcan, Laurence S Magder, Michelle Petri
The Journal of Rheumatology|August 17, 2014
Predictors of incident depression in systemic lupus erythematosusXiangyang Huang, Laurence S Magder, Michelle Petri
The Journal of Rheumatology|December 5, 2002
Antiphospholipid antibodies and incidence of venous thrombosis in a cohort of patients with systemic lupus erythematosusEmily Somers, Laurence S Magder, Michelle Petri
Lupus Science & Medicine|December 22, 2015
Lupus anticoagulant, disease activity and low complement in the first trimester are predictive of pregnancy lossAnil Mankee, Michelle Petri, Laurence S Magder
Pageof 22